Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0HCK stock hub

LON/0HCK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HCKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HCK

In the news

Latest news · LON/0HCK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15

P25 12.9P50 16.9P75 23.5

Trailing P/E27.2

P25 15.9P50 22.9P75 35.8

ROE10.8

P25 -54.2P50 2.1P75 13.7

ROIC17.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HCK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	20,275
Employees Change	-625%
Employees Change Percent	-2.88
Enterprise value	$8.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US0162551016
Last refreshed	2026-05-10
Market cap	$8.9B
Price	$164
Price currency	USD
Rev Per Employee	152,984.54x
Sector	Healthcare
Sic	3843
Symbol	lon/0HCK
Website	https://www.aligntech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.67%
EV Earnings	25.12x
EV/EBIT	15.3x
EV/EBITDA	11.88x
EV/FCF	18.5x
EV/Sales	2.72x
FCF yield	4.98%
Forward P/E	15.04x
P/B ratio	2.82x
P/E ratio	27.25x
P/S ratio	2.86x
PE Ratio10 Y	49.05x
PE Ratio3 Y	42.6x
PE Ratio5 Y	47.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.78%
EBITDA Margin	21.74%
FCF margin	14.25%
Gross margin	70.15%
Gross Profit	$2.2B
Gross Profit Growth	3.58%
Gross Profit Growth Q	10.4%
Gross Profit Growth3 Y	3.75%
Gross Profit Growth5 Y	7.13%
Net Income	$325.6M
Net Income Growth	4.96%
Net Income Growth Q	20.96%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	10.91%
Net Income Growth5 Y	-1.26%
Pretax Margin	14.5%
Profit Margin	10.5%
Profit Per Employee	$16,057
Profitable Years	14
ROA	7.33
Roa5y	7.76
ROCE	16.52
ROE	10.82
Roe5y	13.3
ROIC	17.23
Roic5y	18.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.71%
Cagr3y	-19.34%
Cagr5y	-22.96%
EPS Growth	8.23
EPS Growth Q	23.88
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	13.78
EPS Growth5 Y	0.65
FCF Growth	-6.6%
FCF Growth Q	451.51%
FCF Growth3 Y	7.87%
FCF Growth5 Y	-4.13%
OCF Growth	-9.27%
OCF Growth Q	186.74%
OCF Growth10 Y	11.49%
OCF Growth3 Y	-2.15%
OCF Growth5 Y	-4.7%
Revenue Growth	2.89x
Revenue Growth Q	6.21x
Revenue Growth Quarters	3x
Revenue Growth Years	3x
Revenue Growth3 Y	3.4x
Revenue Growth5 Y	7.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$4.8B
Cash	$802.6M
Current Assets	$1.9B
Current Liabilities	$1.4B
Debt	$87.9M
Debt EBITDA	$0.12
Debt Equity	$0.03
Debt FCF	$0.2
Equity	$3.1B
Liabilities	$1.6B
Long Term Assets	$2.8B
Long Term Liabilities	$241.4M
Net Cash	$714.7M
Net Cash By Market Cap	$8.06
Net Cash Growth	29.42%
Net Debt EBITDA	$-1.06
Net Debt Equity	$-0.23
Net Debt FCF	$-1.62
Tangible Book Value	$2.7B
Tangible Book Value Per Share	$37.62
WACC	13.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	5.3
Net Working Capital	$-210.3M
Quick ratio	1.17
Working Capital	$567.7M
Working Capital Turnover	$5.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.71%
200-day SMA	158.1
3Y total return	-47.54%
50-day SMA	177.8
50-day SMA vs 200-day SMA	50over200
5Y total return	-72.86%
All Time High	738
All Time High Change	-77.81%
All Time High Date	2021-09-09
All Time Low	122.2
All Time Low Change	34%
All Time Low Date	2025-09-25
ATR	9.52
Beta	1.7
Ch YTD	3.69
High	173.9
High52	212
High52 Date	2025-07-28
High52ch	-22.76%
Low	163.3
Low52	122.2
Low52 Date	2025-09-25
Low52ch	34%
Ma50ch	-7.92%
Price vs 200-day SMA	3.54%
RSI	37.45
RSI Monthly	44.56
RSI Weekly	48.58
Sharpe ratio	0.11x
Sortino ratio	0.22
Total Return	3.32%
Tr YTD	3.69
Tr1m	-3.03%
Tr1w	-7.48%
Tr3m	-11.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$551.5M
Operating Income Growth	12.68
Operating Income Growth Q	37.7
Operating Income Growth3 Y	8
Operating Income Growth5 Y	6.47
Operating margin	17.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,039,882%
Shares Insiders	5.57%
Shares Institutions	99.27%
Shares Qo Q	-0.2%
Shares Yo Y	-3.32%
Short Ratio	3.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$304.3M
Average Volume	288.65x
Bv Per Share	43.88
CAPEX	$-81.7M
Ch1m	-3.03
Ch1w	-7.48
Ch1y	-3.71
Ch3m	-11.13
Ch3y	-47.54
Ch5y	-72.86
Ch6m	22.6
Change	-2.59%
Change From Open	-2.77
Close	168.1
Days Gap	0.18
Depreciation Amortization	118,386,959.1
Dollar Volume	37,496.5
Earnings Date	2026-04-29
EBIT	$551.5M
EBITDA	$674.3M
EPS	$4.51
F Score	7
FCF	$442M
FCF EV Yield	5.4x
Financing CF	-231,698,979
Fiscal Year End	December
Founded	1,997
Goodwill	368,987,616.1
Graham Number	88.55665
Graham Upside	-45.92
Income Tax	$124.1M
Investing CF	-165,650,624
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	$30.05
Lynch Upside	-81.65
Ma150	162.3
Ma150ch	0.89%
Ma20	181.5
Ma20ch	-9.76%
Net CF	141,659,959
Next Earnings Date	2026-07-29
Open	168.4
P FCF Ratio	20.07
P OCF Ratio	16.94
Position In Range	4.43
Ppne	893,651,108.9
Price Date	2026-05-08
Price EBITDA	$13.15
Ptbv Ratio	3.29
Relative Volume	0.82x
Revenue	3,101,761,489x
SBC By Revenue	4.44x
Share Based Comp	137,675,777
Tax By Revenue	4x
Tax Rate	27.59%
Tr6m	22.6%
Volume	229
Z Score	4.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HCK pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HCK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HCK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.3%

Share of float held by funds and institutions

Insider ownership

+5.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HCK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.5

Neutral momentum band

Price vs 200-day MA

+3.5%

50/200-day relationship not available

Beta (5Y)

1.70

More volatile than the market

Sharpe ratio

0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HCK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HCK stock rating?

lon/0HCK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HCK analysis?

The full report lives at /stocks/lon/0HCK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HCK?

The latest report frames lon/0HCK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HCK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.